Veroscience Is Committed To Developing Novelpracticaland Effective Therapies For Chronic Debilitating Human Diseases Such As Type 2 Diabetesmetabolic Syndromeautoimmune Diseaseand Cancer Through Interdisciplinary Basic Researchveroscience Researchers Study Biological Clocks In Vertebrates And Their Organizational Influence On Neuroendocrine Regulation Of Physiology To Develop New Treatment Strategies For Metabolic And Immune Disordersby Investigating And Mimicking Nature S Means Of Regulating Biochemical Physiology For Survival Of Vertebrates In The Wildveroscience Develops Treatment Strategiesnot Products Per Seaimed At Re Directing Pathological Biochemistry Back Towards Itsnormalphysiological Organizationa Major Platform Technology Of The Company Is Circadian Neuroendocrine Resetting Therapyathat Is Utilized As A Generator Of Multiple Therapeutic Strategies To Treat A Variety Of Disease Statesthe Circadian Timed Dailymorningadministration Of Cycloseta A Quick Release Formulation Of Bromocriptine Mesylatebromocriptine Qr A Dopamine Agonistwas Developed For The Treatment Of Type 2 Diabetescycloset Is Approved By The U Sfdaindicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus
No conferences found for this company.
| Company Name | Veroscience Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
